NAGE Q1 2025 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M+37.6% YoY

Gross Profit

$19M63.4% margin

Operating Income

$5M15.7% margin

Net Income

$5M16.6% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$81M

Total Liabilities

$26M

Stockholders' Equity

$55M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$22M	+37.6%
Gross Profit	$19M	$13M	+43.7%
Operating Income	$5M	-$731,000	+752.8%
Net Income	$5M	-$492,000	+1129.1%